Llor-Rodriguez, P.; Blasco-Cordellat, A.; Macia-Escalante, S.; Fernández-Murga, L.; Vidal-Martinez, J.; Garde-Noguera, J.; GarcÃa-Sánchez, J.; Llombart-Cussac, A.
The Impact on the Therapeutic Decision of Massive Gene Sequencing (NGS) in Plasma from Patients with Advanced Non-Small Cell Lung Cancer (NSCLC). Cancers 2025, 17, 3469.
https://doi.org/10.3390/cancers17213469
AMA Style
Llor-Rodriguez P, Blasco-Cordellat A, Macia-Escalante S, Fernández-Murga L, Vidal-Martinez J, Garde-Noguera J, GarcÃa-Sánchez J, Llombart-Cussac A.
The Impact on the Therapeutic Decision of Massive Gene Sequencing (NGS) in Plasma from Patients with Advanced Non-Small Cell Lung Cancer (NSCLC). Cancers. 2025; 17(21):3469.
https://doi.org/10.3390/cancers17213469
Chicago/Turabian Style
Llor-Rodriguez, Paula, Ana Blasco-Cordellat, Sonia Macia-Escalante, Leonor Fernández-Murga, José Vidal-Martinez, Javier Garde-Noguera, José GarcÃa-Sánchez, and Antonio Llombart-Cussac.
2025. "The Impact on the Therapeutic Decision of Massive Gene Sequencing (NGS) in Plasma from Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)" Cancers 17, no. 21: 3469.
https://doi.org/10.3390/cancers17213469
APA Style
Llor-Rodriguez, P., Blasco-Cordellat, A., Macia-Escalante, S., Fernández-Murga, L., Vidal-Martinez, J., Garde-Noguera, J., GarcÃa-Sánchez, J., & Llombart-Cussac, A.
(2025). The Impact on the Therapeutic Decision of Massive Gene Sequencing (NGS) in Plasma from Patients with Advanced Non-Small Cell Lung Cancer (NSCLC). Cancers, 17(21), 3469.
https://doi.org/10.3390/cancers17213469
